Lecture 22 - Chemotherapy - Mechanisms of Action NOT FINISHED Flashcards

1
Q

What are the possible uses for chemotherapy?

A
  • primary induction treatment
  • neoadjuvant treatment - debulking prior to surgery or radiotherapy
  • adjuvant treatment following surgery to reduce risk of metastases, mop up micro metastases
  • regional treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is meant by dose-escalation and dose-limiting toxicity?

A
  • efficacy dose similar to toxic dose

- need to give greatest effictive dose that is not lethally toxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What properties of malignant cells does chemotherapy target?

A
  • paracrine/autocriine and hormone factors
  • surface antigens, MHC
  • altered gene expression
  • impaired apoptosis
  • mitogenic signals
  • dysregualted cell cycle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is required of the cell cycle in order to a cell to be susceptibe to killing by chemotherapy?

A
  • an intact apoptotic pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Draw the cell cycle and list the agents that work at each point on it;

  • microtubule inhibitors
  • topoisomerase inhibitors
  • alkylating agents
  • anti-metabolites
  • platinum analogues
A

see lecture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

-
-

A
  • external signalling
  • DNA damage e.g. via p53
  • differentiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do platinum analogues work as chemotherapy?

A
  • diffuse into cell
  • those Cl- groups
  • cross links DNA, prevents DNA, RNA, protein synthesis
  • leads to apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do antimetabolites work as chemotherapy?

A
  • bear a structural similarity to naturally occurring substances such as vitamins, nucleosides or amino acids
  • main classes include folic acid antagonists, purine analogues, pyrimidine analogues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What class of chemotherapy is methotrexate and what is its mechanism of action?

A

Antimetabolite, folic acid antagonist

  • acts at S phase
  • block synthesis of coenzymes involved in the synthesis of DNA and RNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What class of chemotherapy is 5-fluorouracil and what is its mechanism of action?

A

Antimetabolite, pyrimidine analogue

  • inhibit synthesis of nucleic acids
  • inhibiting enzymes of DNA synthesis
  • or becoming incorporated into DNA and interrupting DNA synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the action of anthracyclines?

A
  • topoisomerase II inhibition
  • DNA intercalation –> ss and ds DNA breaks
  • free radical formation - bind to DNA (offtarget toxicity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What stage of the cell cycle to topoisomerase inhibitors work on?

A
  • stop entering mitosis from G2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do topoisomerase I inhibitors work?

A
  • binds to the enzyme DNA complex, stabilising it and prevent DNA replication
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do topoisomerase II inhibitors work?

A
  • stabilise the complex between topoisomerase II and DNA that causes strand breaks and ultimately inhibits DNA replication
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do alkylating agents work?

A
  • covalently linking an alkyl group to a chemical species in proteins or nucleic acids
  • interfere with DNA replication
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the two types of microtubule inhibitors?

A
  • vinca alkaloids

- taxoids

17
Q

How do vinca alkaloids work?

A
  • mitotic spindle poisons
  • bind to tubule, a component of spindles
  • inhibits assembly of spindles
  • affects DNA repair
18
Q

How do taxoids work?

A
  • promotes assembly and inhibits dissasembly

- prevents dynamic reorganisation

19
Q

What are the causes of the off target effects of anthracyclines?
Give examples of these off target effects

A

Caused by free radical formation that bind to DNA

  • myelosupresiso
  • gastrointestinal
  • alopecia
  • local tissue damage
  • cardiotoxicity
20
Q

Therapeutic index

A
  • drugs directed against cell division also effect normal cells
  • normal cells vary in susceptibilty, many are less sensitive than cancer cells
  • normal cells may recover from cytotoxic injury more rapidly than cancer cells
21
Q

Give examples of the reversible toxicities of chemotherapy

A

Affects rapidly dividing cells:

  • bone marrow
  • GI tract
  • germinal epithelium
  • lymphoid tissue
  • hair follicles
22
Q

What does reversibility of toxicities reflect?

What does this determine?

A
  • reflects compartment repopulation by recruitment of resting stem cells and dictates time for recovery between treatment cycles
23
Q

Give examples of irreversible cumulative toxicities
What effects do they reflect?
What do they dictate?

A

Target slow growing cells:
- kidney
- nerves
- heart
- lungs
Reflects the individual physicochemical properties of different classes of drugs
Dictates maximum safe cumulative exposure

24
Q

What is growth fraction?
How does it change in different tumour sizes?
When is it highest?

A
  • the proportion are tumour cells that are dividing
  • clinically undetectable tumours ave the highest growth fraction
  • large tumour mass –> small number of cells susceptible to cytotoxic therapy
25
Q

What are the aims of combination chemotherapy?

A
  • to achieve maximum cell kill with tolerable toxicity
  • increases the kill fraction of resistant cells in a heterogenous tumour population
  • prevent or slow the outgrowth of resistance malignant clones
26
Q

What are the principles of combination chemotherapy?

A
  • only drugs shown to be partially effective - participatory achieving full responses
  • avoid overlapping toxicities on a single organ system
  • optimal dose and schedule
  • treatment-free terava should be shortest comptabilie with recovery of the most sensitive normal tissue
  • monitor respones, performance status and toxicity
  • sequential regimens out-perform alternating regimens
27
Q
  • Dose reductions for toxicity can reduce chance of …….

- Dose delays enable fast growing micro-metastases to …….

A

cure

recover

28
Q

As tumour size increases, mean fraction resistant cells ………..

A

increases

29
Q

Phase I trials use ……… …… as surrogate marker for efficacy
Phase II trials use ……… ……… as surrogate marker for clinical benefit

A
  • acute toxicity

- tumour shrinkage